Stock listing
GLENMARK Stock Price, News, Filings & Events — Glenmark Pharmaceuticals Limited
Selected listing: GLENMARK · BSE · INR · IN
This page tracks Glenmark Pharmaceuticals Limited's GLENMARK:BSE listing on BSE in INR for IN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLENMARK:BSE. GLENMARK:BSE is the stock-level entry point for investors researching Glenmark Pharmaceuticals Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Glenmark Pharmaceuticals Limited, trading under the ticker GLENMARK, is a public company based in India with a market capitalization of approximately $6.7 billion. The company specializes in the development and manufacturing of a wide range of pharmaceutical products. Glenmark is committed to innovation and improving health outcomes through its diverse portfolio.

- Ticker
- GLENMARK:BSE
- Asset type
- Stock
- Market cap
- $6.85B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BSE
- Currency
- INR
Glenmark Pharmaceuticals Limited GLENMARK:BSE stock context
This page tracks Glenmark Pharmaceuticals Limited's GLENMARK:BSE listing on BSE in INR for IN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLENMARK:BSE. GLENMARK:BSE is the stock-level entry point for investors researching Glenmark Pharmaceuticals Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Glenmark Pharmaceuticals Limited, trading under the ticker GLENMARK, is a public company based in India with a market capitalization of approximately $6.7 billion. The company specializes in the development and manufacturing of a wide range of pharmaceutical products. Glenmark is committed to innovation and improving health outcomes through its diverse portfolio.
Latest news from Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Press Release Aug 21 2026
August 20, 2026
Glenmark Pharmaceuticals Limited Press Release Aug 20 2026
August 19, 2026
Glenmark Pharmaceuticals Limited Press Release Jul 31 2026
July 31, 2026
Glenmark Pharmaceuticals Limited Press Release Jul 28 2026
July 28, 2026
Glenmark Pharmaceuticals Limited Press Release Jul 21 2026
July 20, 2026
Research Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited investor report
Review AI stock analysis and investor report context for GLENMARK:BSE.
Glenmark Pharmaceuticals Limited company profile
View the public company page for Glenmark Pharmaceuticals Limited on 6ix.
Glenmark Pharmaceuticals Limited news
Read company news and market updates connected to Glenmark Pharmaceuticals Limited.
Glenmark Pharmaceuticals Limited investor events
Find investor webinars, events, and replay context for Glenmark Pharmaceuticals Limited.